Physician profile
Jin S Park
NPI 1164400768
$15,658.31
in general payments reported to CMS, 2019-2025
57 companies · $2,673 in 2025
The $2,673 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,080 · 2020: $2,759 · 2021: $2,126 · 2022: $1,875 · 2023: $2,486 · 2024: $1,659 · 2025: $2,673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,789 · Education: $28.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,789.32 |
| Education | $28.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,831.83 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $1,390.46 | 2019-2025 | |
| Amgen INC. | $1,348.44 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $1,217.83 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $1,070.55 | 2019-2025 | Watchman Flx, Watchman Access System, Farapulse |
| Pfizer INC. | $1,046.83 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $730.12 | 2019-2024 | |
| Abbott Laboratories | $683.17 | 2019-2024 | Amplatzer Talisman, Amplatzer Amulet |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $485.73 | 2020-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $455.50 | 2019-2025 | Camzyos, Eliquis |
| Kowa Pharmaceuticals America, INC. | $455.46 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $444.59 | 2019-2025 | Andexxa |
| Novo Nordisk INC | $442.97 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Kestra Medical Technology Services, INC. | $440.11 | 2022-2025 | Assure Wcd |
| Endologix LLC | $410.25 | 2025 | Torus Stent Graft System, Endocross Device |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $353.91 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $339.65 | 2019-2025 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $304.59 | 2021-2022 | |
| Medtronic, INC. | $196.35 | 2021-2023 | Resolute Onyx, Micra |
| Daiichi Sankyo INC. | $173.61 | 2021-2024 | Injectafer |
| Alnylam Pharmaceuticals INC. | $146.43 | 2022-2025 | Amvuttra |
| Gilead Sciences, INC. | $124.06 | 2019 | |
| Merck Sharp & Dohme LLC | $118.82 | 2021-2025 | Verquvo |
| Bridgebio Pharma, INC. | $117.53 | 2025 | Attruby |
| United Therapeutics Corporation | $99.62 | 2019-2024 | |
| Penumbra, INC. | $99.20 | 2022-2025 | Indigo System |
| Regeneron Healthcare Solutions, INC. | $80.52 | 2023-2025 | Evkeeza |
| Atricure, INC. | $73.48 | 2019-2023 | |
| Kiniksa Pharmaceuticals International, Plc | $73.22 | 2024 | Arcalyst |
| Philips North America LLC | $71.53 | 2020-2025 | Igt Devices Undivided |
| Cleerly, INC. | $67.04 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Kiniksa Pharmaceuticals, LTD. | $66.03 | 2023 | Arcalyst |
| Genzyme Corporation | $61.82 | 2023-2025 | |
| Amarin Pharma, INC. | $61.07 | 2019-2021 | |
| Esperion Therapeutics, INC. | $58.01 | 2021-2025 | Nexletol |
| Abiomed | $49.07 | 2021-2022 | |
| Bardy Diagnostics, INC. | $41.49 | 2020-2021 | |
| Preventice Services, LLC | $37.01 | 2021 | |
| Csl Behring | $36.66 | 2021 | |
| Cook Medical LLC | $35.92 | 2024 | Icast Covered Stent System, 6mmx22mmx120cm |
| Cardinal Health 200 LLC | $35.89 | 2019-2020 | |
| Cardiva Medical, INC. | $30.33 | 2024 | Cardiva Vascade 6/7f Vcs |
| Arbor Pharmaceuticals, INC. | $29.12 | 2020-2021 | |
| Angiodynamics, INC. | $27.68 | 2020 | |
| Reflow Medical INC | $22.06 | 2025 | |
| Lilly USA, LLC | $20.55 | 2025 | Zepbound |
| Heartflow, INC. | $19.64 | 2025 | |
| Teleflex LLC | $17.43 | 2025 | Guideliner |
| Scpharmaceuticals INC. | $15.25 | 2024 | |
| Baxter Healthcare | $14.56 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Azurity Pharmaceuticals, INC. | $13.57 | 2025 | Edarbi |
| Impulse Dynamics (USA) INC. | $13.47 | 2021 | |
| Chiesi USA, INC. | $13.29 | 2024 | Juxtapid |
| Elutia, INC. | $12.16 | 2019 | |
| Shockwave Medical, INC | $12.13 | 2022 | |
| Infobionic, INC | $11.09 | 2020 | |
| Cvrx, INC. | $9.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jin Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.